4 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
Follow Personality Disorders: new trials by email Literature Review of Personality Disorders trials Research Report on Personality Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ketamine in Borderline Personality Disorder Ketamine, Midazolam - Borderline Personality Disorder | Phase 2 | Terminated | Yale University | 22 | 2018-02-15 | 2023-06-26 |
| Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder Escitalopram - Borderline Personality Disorder | Phase 2 | Terminated | University of Chicago | 70 | 2010-09-01 | 2019-06-14 |
| Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) mifepristone, Placebo - Borderline Personality Disorder | Phase 2 | Terminated | Indiana University | 22 | 2010-09-01 | 2019-02-26 |
| N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD N-Acetylcysteine, placebo - Borderline Personality Disorder, Self-Injurious Behavior | Phase 2 | Terminated | Yale University | 6 | 2007-09-01 | 2020-04-15 |
Borderline Personality Disorder (4) · Self-Injurious Behavior (2) · Depressive Disorder, Major (1) · Suicide (1)
Mental Disorders (4) · Behavior (3) · Behavioral Symptoms (3) · Depressive Disorder (1) · Mood Disorders (1) · Self-Injurious Behavior (1)
Acetylcysteine (1) · Escitalopram (1) · Ketamine (1) · Midazolam (1) · Mifepristone (1)
Yale University (2) · Indiana University (1) · University of Chicago (1)
United States (4)
Christopher J Pittenger, MD,PhD (1) · Emil F Coccaro, M.D. (1) · Michael S McCloskey, Ph.D (1) · Sarah Fineberg, MD/PhD (1)